Skip to main content
Aarey Drugs & Pharmaceuticals Ltd logo

Aarey Drugs & Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · AAREYDRUGS ISIN · INE198H01019 LEI · 984500B707D10391FC73 BSE.NS Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2026-05-25 Report Publication Anno…
Country IN India
Listing BSE.NS AAREYDRUGS

About Aarey Drugs & Pharmaceuticals Ltd

https://www.aareydrugs.com

Aarey Drugs & Pharmaceuticals Ltd specializes in the manufacturing and distribution of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. The company maintains a diverse product portfolio featuring bulk drugs such as Metronidazole, Metronidazole Benzoate, Tinidazole, and Methyl Nitro Imidazole. These products cater to various therapeutic applications, including anti-infective and anti-protozoal treatments. Utilizing integrated manufacturing processes, the firm supplies high-quality chemical components to a global clientele, serving both domestic and international pharmaceutical sectors. Its core competencies lie in complex chemical synthesis and the production of nitroimidazole derivatives, supported by rigorous quality assurance protocols to meet international standards for medicinal raw materials.

Recent filings

Filing Released Lang Actions
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Pursuant to the ....
Report Publication Announcement Classification · 80% confidence The document is a formal notice to stock exchanges under SEBI Listing Regulations (Regulation 29) informing them of a scheduled Board of Directors meeting to consider and approve the audited financial results. It contains no actual financial data or results itself but rather announces the timing and agenda for the report’s approval and release. This fits the definition of a “Report Publication Announcement” (RPA): an announcement regarding the timing or publication of company reports.
2026-05-25 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 85% confidence The document is a letter to the stock exchange clarifying an error in previously submitted financial results and announcing the filing of revised Integrated Financial Results in the prescribed format. It contains no actual financial statements or data, but serves as a regulatory submission/correction notice. This fits the catch-all Regulatory Filings category.
2026-05-11 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2026. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialisation of securities and related compliance. The document is short (3172 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents that do not fit other specific categories.
2026-04-14 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window for insiders and designated persons. It references SEBI regulations on insider trading and mentions the upcoming declaration of audited financial results for the fiscal year ending March 31, 2026. The document does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (2238 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance-related notices that do not fit other specific categories.
2026-03-26 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-14 English
Updates
Regulatory Filings
2026-02-12 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.